Showing posts with label PS. Show all posts
Showing posts with label PS. Show all posts

Sunday, 21 December 2014

Psilocybin: The Science Behind a Magical Molecule


Psilocybin is a naturally occurring psychedelic compound found in many species of mushrooms. In this form it has a long history of use by Man in the context of healing and divination, and it is still employed in this manner today by indigenous groups such as the Mazatec. Since the 1960’s awareness of psilocybin and the fungi within which it resides has spread into the Western world. Following the legal clamp down that resulted from widespread use of this and other psychedelics like LSD and mescaline at this time, scientific research into this compound and other psychedelics all but drew to a halt. In the last few years regulatory red tape has been loosening to some degree, and scientists have began studying psilocybin for a number of reasons. It appears that psilocybin is a highly multifaceted compound and has the capacity to act as a profound tool in the study of the brain and consciousness, as well as act as a treatment for a variety of psychological conditions.
Psilocybin is a compound of very low physical toxicity, but it can exert very powerful psychological effects, and the correct set and setting are of key importance when the drug is administered to reduce the chances of adverse reactions and to maximise potential benefits. On ingestion, psilocybin is dephosphorylated into the pharmacologically active molecule psilocin which closely resembles a key neurotransmitter serotonin in structure, and because of this it had a high affinity for 5-HT2A and 5-HT1 serotonin receptors where it mimics the effect of the neurotransmitter. The psychedelic effects of psilocybin can be prevented by the chemical ketanserin, which acts as a 5-HT2A receptor antagonist, blocking psilocybin’s access to the receptor sites and preventing it from exerting an effect (Vollenweider et al. 1999). These receptors are located at varying densities in many parts of the brain, and play important roles in mood and motivation regulation, among other things. At medium doses psilocybin has also been found to increase an increase in cerebral metabolic rate of glucose, particularly in the frontomedial and frontolateral cortex (24.3%), anterior cingulate (24.9%) and temporomedial cortex (25.3%) brain regions (Vollenweider et al. 1997).
Recent technological developments such as functional magnetic resonance imaging (fMRI) are allowing researchers to examine the brain with greater precision and less invasively than ever before. Brain imaging studies of healthy volunteers under psilocybin have found that brain activity was reduced in the default-mode network via a reduction in blood flow, and hub regions such as the thalamus and anterior and posterior cingulate cortex were affected, and this in turn has downstream effects on consciousness, leading to a more unconstrained, expansive and free flowing state when compared to cognition in a sober state (Carhart-Harris et al. 2012). An overactive default mode network is associated with depressive states and obsessive rumination, so a reduction in activity of this network may have important implications for the treatment of depression. A reduction of activity in the default-mode network is also linked to experiences of ego dissolution commonly associated with psilocybin. This network is linked to our personality and sense of self, with the latter being experienced as less solid under psilocybin, and there is a sense of novelty, with people commonly describing experiencing the world akin to new, as through child like eyes. Activity in the medial prefrontal cortex was consistently decreased by psilocybin, which is of interest as this area has been observed to be hyperactive in people experiencing major depressive episodes. Mindfulness meditation has also been found to reduce activity in these same brain regions.
More brain imaging research has also shown the psilocybin enhances autobiographical recollection and facilitates the recall of memories in a vivid fashion in healthy volunteers, and that there was a correlation between vividness of memories and subjective well being at a two week follow up after the session. Increased activity in brain regions that process visual and other sensory information was also observed. This aspect of psilocybin suggests it may be an aid to psychotherapy as a tool to facilitate the recall of salient memories or to aid in the reduction of fixation on negative memories, while also having the potential to enhance creative thinking (Carhart-Harris et al. 2012).
Further brain imaging research has built on this past research and shown that psilocybin increases the amplitude of activity in brain regions that are reliably activated during dream sleep and which form part of the brains more ancient and primitive emotion system. At the same time an expanded state of consciousness is facilitated, with respect to an increased breadth of associations made by the brain under the drug and the ease with which this occurs compared to sober states (Tagliazucchi et al. 2014). This research indicates that psilocybin may allow access to waking dream states, and so allow active unconscious emotional processing and learning that is associated with dreaming, while also being an aid in creative thinking and problem solving, while having therapeutic applications for its ability to access the primal parts of the brain. It appears the state of consciousness resulting from psilocybin ingestion leads to disorganised and reduced activity in the ego system which in turn permits disinhibited and increased activity on the emotion system. This builds on evidence in other studies with the compound that psilocybin may be a useful aid for certain forms of psychotherapy.
Further analysis of the recent MRI findings of human brains under psilocybin has shown that the drug increases connection and communication between brain regions that are usually more disconnected in a sober state, and in an organised and stable fashion; the brain’s connectivity pattern is distinctly different under psilocybin. It is possible that experiences such as synaesthesia reported under psychedelics, where different sensory perceptions cross over and merge, may occur due to these alterations in brain connectivity. The function of the brain under psilocybin can be described as less constrained and more intercommunicative compared to a sober brain state (Petri et al. 2014).
More recent research has shown that psilocybin administration results in reduced amygdala reactivity, which in turn is correlated with positive mood in healthy volunteers (Kraehenmann et al. 2014). Thus, psilocybin may have potential as a treatment for anxiety and depression, with amygdala overactivity linked with negative mood states in patients with major depression. Research into psilocybin’s role as a treatment for depression and anxiety is ongoing. Current anti-depressant treatments only dampen symptoms, require chronic use to be effective, are only effective for a certain proportion of people, they tend to come with a range of side effects, and for some such as the commonly prescribed SSRI’s, withdrawals can be prolonged. Psilocybin could provide an alternative, more effective way of treating depression than is currently employed.
Research supported by MAPS and led by Francisco Moreno at the University of Arizona compromised the first FDA approval clinical pilot study of psilocybin in the US since 1970, and it was focussed on the treatment of obsessive-compulsive disorder (OCD). It was found that psilocybin administration resulted in a significant reduction in OCD symptoms in a number of patients (Moreno et al. 2006), and this is hypothesised to occur via a downregulation of serotonin receptors, resulting in a reduced responsiveness to serotonin (Halberstadt & Geyer 2011).
Psilocybin has been found to reduce the pain and symptoms of cluster headaches (Vollenweider & Kometer 2010; Sun-Edelstein & Mauskrop 2011) which are highly debilitating, are considered one of the most painful syndromes known to Man and are linked to a high suicide rate. No other treatments are known to stop cluster headache cycles and sub-psychedelic doses of psilocybin (and LSD) are effective. Psilocybin has been found to decrease blood flow in the hypothalamus, where blood flow increases during cluster headache episodes, which may partly explain its efficacy in treating this condition (Carhart-Harris et al. 2012). Further research in this area is certainly warranted.
Recent studies have used psilocybin in the treatment of alcoholism and tobacco addiction. A recently completed pilot study with 15 participants using medium and large doses of the drug yielded highly promising preliminary results, and further research is certainly warranted. 12 of 15 study participants (80%) showed abstinence at a six month follow up, while current treatments for tobacco addiction have a much lower success result, not exceeding 35% (Johnson et al. 2014). This was a small pilot study to test the feasibility of using psilocybin to treat tobacco addiction so it is important not to draw any definitive conclusions regarding the efficacy of psilocybin in treating tobacco addiction, but the results are certainly encouraging and supportive of further research.
Psychedelics like psilocybin act in a number of different ways in the brain to affect addictive syndromes. They act on the receptors in the brain associated with drug seeking behaviour, while reducing blood flow to areas of the brain associated with emotional processing and higher function that tend to be overactive in depressives. This can restrain negative circular thought patterns associated with addiction. The temporary chaotic state induced by psychedelics seems to weaken reinforced brain connections and dynamics and the experience provides a window of reflection where people can view their life and addiction issues from a wider perspective. People who were more successful in quitting smoking had higher ‘mystical experience’ scores, and in other studies, the psilocybin induced mystical experience was found to cause positive changes in measures of life satisfaction and well being, as well as long term personality change, particularly in openness.
Low doses of the compound, and chronic high doses have recently been found to increase hippocampal neurogenesis in mice, and increased the speed of their ‘unlearning’ of negative fear behaviour responses when compared to drug free controls, an effect that may hold promise in the treatment of post-traumatic stress disorder (PTSD) and related pathologies (Catlow et al. 2013). Thus psilocybin may have applications for treating PTSD in humans, a syndrome characterised by highly abnormal brain function, including impaired hippocampal function (Shin et al. 2006). Impaired hippocampal neurogenesis has also been implicated in cognitive disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), addiction (Canales 2013) and neurodegenerative diseases. The psilocybin was also found to decrease activity in the medial frontal cortex regions of the mice, this area being linked to overactivity in sufferers of PTSD, and this has also been observed in human studies (Carhart-Harris et al. 2012). It may be that psilocybin, like ketamine, alters glutamatergic neurotransmission, this being linked with neurogenesis and neuroplasticity in the brain (Vollenweider & Kometer 2010).
Psilocybin is being studied for its efficacy at assisting terminally ill cancer patients by easing their psychological suffering implicated with their approaching death. Initial results, where low doses of the drug are employed, combined with supportive psychotherapy, show great promise in psilocybin assisting people by reducing anxiety and existential angst, reducing dependency on pain medication following the session and allowing people to make the most of their remaining time. Effects from a single psilocybin session can be long term, with effects lasting from two weeks up to six months and beyond (Vollenweider & Kometer 2010; Grob et al. 2011). Further research in this area is ongoing, and is being conducted by Dr Stephen Ross of New York University with support from the Heffter Research Institute.
Research with high doses of psilocybin have found it can induce long term, positive changes in personality and feelings of life satisfaction and well being (Griffiths et al. 2011). Openness is one of the five measures of personality, and can be significantly changed in the long term by a single dose of psilocybin, especially if people have a mystical experience during a session (Griffiths et al. 2011). This is of great interest, as after the age of 30 personality is thought to be generally fixed in the individual, and openness is thought to decline with age, hinting that psilocybin can influence neuroplasticity of the brain. This change in personality remained as strong 14 months after the session, and appears to be long term (Griffiths et al. 2011). Openness covers personality traits such as an appreciation for new experiences, broadness of imagination and finding value in aesthetics, emotion, curiosity and creativity, with an increased hunger for knowledge (MacLean et al. 2011).
Psilocybin may have application in psychical research. In 1997 there was some research into how psilocybin could influence results from remote viewing conducted by students at the University of Amsterdam. In the experiment, test-subjects under the influence of cannabis selected the right target only slightly above chance expectancy. Test-subjects under the influence of psilocybin selected the target with a success rate of 58.3%, which is a statistically significant result. The experiment was small however with only 12 subjects, but further research with larger sample sizes is warranted (Millay 1999).
This is an exciting time for psilocybin research. The last few years has seen an explosion in research, and this itself indicates that the strongly anti psychedelic mind-set in scientific circles, a hangover from the 1960’s, is beginning to dissipate, and researchers now have cutting edge technologies such as fMRI to aid them in the work and increase the precision and breadth of their findings. Research in many areas is ongoing, and new avenues for enquiry are opening up. David Nutt and his team at Imperial College are conducting a study on the efficacy of psilocybin as a treatment for depression, building on their previous work there. Just months ago a pilot study was completed in the US, based at John Hopkins University, looking at the effects of psilocybin on behaviour, psychology and brain function in long-term meditators. Psilocybin has a long history of use by Man, and has been revered as a powerful medicine and ally for a very long time. Modern science is confirming and building on ancient wisdom to allow us to better understand this amazing and highly multifaceted molecule, in order that we can better utilise its tremendous capacity to heal people.

Notes
Canales, J.J. (2013) Deficient plasticity in the hippocampus and the spiral of addiction: focus on adult neurogenesis. Current Topics in Behavioural Neuroscience, 15, 293-312.
Catlow, B.J., Song, S., Paredes, D.A., Kirstein, C.L. & Sanchez-Ramos, J. (2013) Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Experimental Brain Research, 228, (4), 481-491.
Carhart-Harris, R.L., Erritzoe, D., Williams, T. Stone, J.M., Reed, L.J., Colasanti, A., Tyacke, R.J., Leech, R., Malizia, A.L., Murphy, K., Hobden, P., Evans, J., Fielding, A., Wise, R.G. & Nutt, D.J. (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences of the United States of America, 109, 2138-2143.
Carhart-Harris, R.L., Leech, R., Williams, T.M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D.J., Evans, J., Feilding, A., Wise, R.G. & Nutt, D.J. (2012) Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. The British Journal of Psychiatry, 200, (3), 238-244.
Griffiths, R.R., Johnson, M.W., Richards, W.A., McCann, U. & Jesse, R. (2011) Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology (Berl), 218, 649-665.
Grob, C.S., Danforth, A.L., Chopra, G.S., Hagerty, M., McKay, C.R., Halberstadt, A.L. & Greer, G.R. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68, (1), 71-78.
Halberstadt, A.L. & Geyer, M.A. (2011). Multiple receptors contribute to the behavioural effects of indoleamine hallucinogens. Neuropharmacology, 61, (3), 364–81.
Johnson, M.W., Garcia-Romeu, A., Cosimano, M.P. & Griffiths, R.R. (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology. In Press.
Millay, J. (1999) Multidimensional Mind: Remote Viewing in Hyperspace. North Atlantic Books, Berkeley, California, USA.
Kellner M. (2010). Drug treatment of obsessive-compulsive disorder. Dialogues in Clinical Neuroscience, 12, (2), 187–97.
Kraehenmann, R., Preller, K.H., Scheidegger, M. Pokorny, T., Bosch, O.G., Seifritz, E. & Vollenweider, F. X. (2014) Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Biological Psychiatry. In Press.
MacLean, K.A., Johnson, M.W. & Griffiths, R.R. (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25, (11), 1453-1461.
Moreno, F.A., Wiegand, C.B., Taitano, K. & Delgado, P.L. (2006) Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry, 67, 1735-1740.
Petri, G., Expert, P., Terkheimer, F., Carhart-Harris, R., Nutt, D., Hellyer, P.J. & Vaccarino, F. (2014) Homological scaffolds of brain functional networks. Journal of the Royal Society Interface, 11, (101), e20140873.
Shin, L.M., Rauch, S.L. & Pitman, R. K. (2006) Amygdala, Medial Prefrontal Cortex, and Hippocampal Function in PTSD. Annals of the New York Academy of Sciences, 1071, 67-79.
Sun-Edelstein C, Mauskop A. (2011). “Alternative headache treatments: nutraceuticals, behavioral and physical treatments”. Headache: the Journal of Head and Face Pain, 51, (3), 469–83.
Tagliazucchi, E., Carhart-Harris, R., Leech, R., Nutt, D. & Chialvo, D.R. (2014) Enhanced repertoire of brain dynamical states during the psychedelic experience. Human Brain Mapping. In Press.
Vollenweider, F.X. & Kometer, M. (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nature Reviews Neuroscience, 11, (9), 642–51.
Vollenweider, F.X., Leenders, K.L., Scharfetter, C., Maguire, P., Stadelmann, O. & Angst, J. (1997) Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis. Neuropsychopharmacology, 16, (5), 357-372.
Vollenweider, F.X., Vontobel, P., Hell, D. & Leenders, K.L. 5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man-A PET Study with [11C]raclopride. Neuropsychopharmacology, 20, (5), 424-433.
Image by afgooey74, courtesy of Creative Commons license.

Sunday, 16 November 2014

Launch of the Psychedelic Society in London

Courtesy of the Psychedelic Society
Courtesy of the Psychedelic Society
The inaugural meeting of the Psychedelic Society (PS) – Mainstreaming Psychedelics – took place in Conway Hall, London on November 3. Nearly 400 people, representing different age groups and backgrounds, gathered together to watch four short talks. The speakers, and perhaps more importantly their fields, clearly indicated the ground on which the PS plan to operate.
Prof. David Nutt, psychopharmacologist and former chairman of the Advisory Council on the Misuse of Drugs, discussed some of the latest research on psychedelics, and it was a mark of how well attended the event was that a number of the scientists Prof. Nutt cited in his talk were sat in the audience. The scientific community has made great headway with psychedelics over the last few years, and PS is clearly keen to aid this effort.
Evidence-based approaches in the sciences were also coupled with those of activism, policy, and harm reduction. There were talks from Steve Rolles, senior policy analyst at Transform Drug Policy Foundation; David Babbs from 38 Degrees, the activism and petition website; and Arielle Nylander, a harm reductionist who conducted research in the festival scene.
There was a real sense of not only bringing about a change in law and science, but providing for the existing psychedelic community as well – even if a number of the more experienced trippers and harm reductionists watching winced at some of the clinical terminology. I might add that rummaging through my tent at three in the morning – i.e. not preparing a ‘trip bag’ – has led to some very enjoyable adventures trying to find my way out.
And while this was certainly no 1965 Poetry Incarnation, where the scattered tribes of the British Underground came together in mutual recognition of the others, there was a seed of this energy at Conway Hall and definitely a collective sense of purpose.
Grassroots activism in the psychedelic arena takes two forms by and large, chemistry and politics, and I’ve been led to believe we’ve been short of both for some time. The timing is right for an organisation to rally political causes, just as the scientific community has been doing for a number of years, and while it remains to be seen how this will manifest in the Psychedelic Society, they’ve certainly kicked off on the right foot.

Sunday, 23 December 2012

Ancient Origins of Santa Claus: The psychedelic shamanistic traditions

Modern Christmas traditions are based on ancient mushroom-using shamans.
Although most people see Christmas as a Christian holiday, most of the symbols and icons we associate with Christmas celebrations are actually derived from the shamanistic traditions of the tribal peoples of pre-Christian Northern Europe.
Most of the major elements of the modern Christmas celebration, such as Santa Claus, Christmas trees, magical reindeer and the giving of gifts, are originally based upon the traditions surrounding the harvest and consumption of these most sacred mushrooms.

“The Pharmacratic Inquisition” that talks about all of these things in detail. Definitely worth watching if you are interested in these subjects and how they influence culture. Funny how most people today don’t really know very much about the things they celebrate. I would argue that it is somewhat pointless to be a culture without knowing its origins, especially considering how much it has become skewed and twisted from its original meaning.
The sacred mushroom of these people was the red and white amanita muscaria mushroom, also known as “fly agaric.” These mushrooms are now commonly seen in books of fairy tales, and are usually associated with magic and fairies. This is because they contain potent hallucinogenic compounds, and were used by ancient peoples for insight and transcendental experiences.
The Pharmacratic Inquisition: The Suppression of Direct Religious Experience, Sexuality and Drugs. Christianity’s Darkest Secrets Revealed.
This is a 3.5 hour lecture, regarding the origins of religion.
As above So below – This video covers both aspects of Christianity: God’s son in heaven, the risen savior; and God’s son on earth, whose flesh and blood is consumed.
This video is presented by Jan Irvin and Andrew Rutajit, authors of the book, “Astrotheology & Shamanism – Unveiling the Law of Duality in Christianity and Other Religions” A fantastic foreward was written for these authors by their friend Jordan Maxwell.
The world tree
These ancient peoples, including the Lapps of modern-day Finland, and the Koyak tribes of the central Russian steppes, believed in the idea of a World Tree. The World Tree was seen as a kind of cosmic axis, onto which the planes of the universe are fixed. The roots of the World Tree stretch down into the underworld, its trunk is the “middle earth” of everyday existence, and its branches reach upwards into the heavenly realm.
The amanita muscaria mushrooms grow only under certain types of trees, mostly firs and evergreens. The mushroom caps are the fruit of the larger mycelium beneath the soil which exists in a symbiotic relationship with the roots of the tree. To ancient people, these mushrooms were literally “the fruit of the tree.”
The North Star was also considered sacred, since all other stars in the sky revolved around its fixed point. They associated this “Pole Star” with the World Tree and the central axis of the universe. The top of the World Tree touched the North Star, and the spirit of the shaman would climb the metaphorical tree, thereby passing into the realm of the gods. This is the true meaning of the star on top of the modern Christmas tree, and also the reason that the super-shaman Santa makes his home at the North Pole.
Ancient peoples were amazed at how these magical mushrooms sprang from the earth without any visible seed. They considered this “virgin birth” to have been the result of the morning dew, which was seen as the semen of the deity. The silver tinsel we drape onto our modern Christmas tree represents this divine fluid.
Reindeer games
The active ingredients of the amanita mushrooms are not metabolized by the body, and so they remain active in the urine. In fact, it is safer to drink the urine of one who has consumed the mushrooms than to eat the mushrooms directly, as many of the toxic compounds are processed and eliminated on the first pass through the body.
It was common practice among ancient people to recycle the potent effects of the mushroom by drinking each other’s urine. The amanita’s ingredients can remain potent even after six passes through the human body. Some scholars argue that this is the origin of the phrase “to get pissed,” as this urine-drinking activity preceded alcohol by thousands of years.
Reindeer were the sacred animals of these semi-nomadic people, as the reindeer provided food, shelter, clothing and other necessities. Reindeer are also fond of eating the amanita mushrooms; they will seek them out, then prance about while under their influence. Often the urine of tripped-out reindeer would be consumed for its psychedelic effects.
This effect goes the other way too, as reindeer also enjoy the urine of a human, especially one who has consumed the mushrooms. In fact, reindeer will seek out human urine to drink, and some tribesmen carry sealskin containers of their own collected piss, which they use to attract stray reindeer back into the herd.
The effects of the amanita mushroom usually include sensations of size distortion and flying. The feeling of flying could account for the legends of flying reindeer, and legends of shamanic journeys included stories of winged reindeer, transporting their riders up to the highest branches of the World Tree.
Santa Claus, super shaman
Although the modern image of Santa Claus was created at least in part by the advertising department of Coca-Cola, in truth his appearance, clothing, mannerisms and companions all mark him as the reincarnation of these ancient mushroom-gathering shamans.
One of the side effects of eating amanita mushrooms is that the skin and facial features take on a flushed, ruddy glow. This is why Santa is always shown with glowing red cheeks and nose. Even Santa’s jolly “Ho, ho, ho!” is the euphoric laugh of one who has indulged in the magic fungus.
Santa also dresses like a mushroom gatherer. When it was time to go out and harvest the magical mushrooms, the ancient shamans would dress much like Santa, wearing red and white fur-trimmed coats and long black boots.
These peoples lived in dwellings made of birch and reindeer hide, called “yurts.” Somewhat similar to a teepee, the yurt’s central smokehole is often also used as an entrance. After gathering the mushrooms from under the sacred trees where they appeared, the shamans would fill their sacks and return home. Climbing down the chimney-entrances, they would share out the mushroom’s gifts with those within.
The amanita mushroom needs to be dried before being consumed; the drying process reduces the mushroom’s toxicity while increasing its potency. The shaman would guide the group in stringing the mushrooms and hanging them around the hearth-fire to dry. This tradition is echoed in the modern stringing of popcorn and other items.
The psychedelic journeys taken under the influence of the amanita were also symbolized by a stick reaching up through the smokehole in the top of the yurt. The smokehole was the portal where the spirit of the shaman exited the physical plane.
Santa’s famous magical journey, where his sleigh takes him around the whole planet in a single night, is developed from the “heavenly chariot,” used by the gods from whom Santa and other shamanic figures are descended. The chariot of Odin, Thor and even the Egyptian god Osiris is now known as the Big Dipper, which circles around the North Star in a 24-hour period.
In different versions of the ancient story, the chariot was pulled by reindeer or horses. As the animals grow exhausted, their mingled spit and blood falls to the ground, forming the amanita mushrooms.
St Nicholas and Old Nick:

Saint Nicholas is a legendary figure who supposedly lived during the fourth Century. His cult spread quickly and Nicholas became the patron saint of many varied groups, including judges, pawnbrokers, criminals, merchants, sailors, bakers, travelers, the poor, and children.
Most religious historians agree that St Nicholas did not actually exist as a real person, and was instead a Christianized version of earlier Pagan gods. Nicholas’ legends were mainly created out of stories about the Teutonic god called Hold Nickar, known as Poseidon to the Greeks. This powerful sea god was known to gallop through the sky during the winter solstice, granting boons to his worshippers below.
When the Catholic Church created the character of St Nicholas, they took his name from “Nickar” and gave him Poseidon’s title of “the Sailor.” There are thousands of churches named in St Nicholas’ honor, most of which were converted from temples to Poseidon and Hold Nickar. (As the ancient pagan deities were demonized by the Christian church, Hold Nickar’s name also became associated with Satan, known as “Old Nick!”)
Local traditions were incorporated into the new Christian holidays to make them more acceptable to the new converts. To these early Christians, Saint Nicholas became a sort of “super-shaman” who was overlaid upon their own shamanic cultural practices. Many images of Saint Nicholas from these early times show him wearing red and white, or standing in front of a red background with white spots, the design of the amanita mushroom.
St Nicholas also adopted some of the qualities of the legendary “Grandmother Befana” from Italy, who filled children’s stockings with gifts. Her shrine at Bari, Italy, became a shrine to St Nicholas.
Modern world, ancient traditions
Some psychologists have discussed the “cognitive dissonance” which occurs when children are encouraged to believe in the literal existence of Santa Claus, only to have their parents’ lie revealed when they are older. By so deceiving our children we rob them of a richer heritage, for the actual origin of these ancient rituals is rooted deep in our history and our collective unconscious. By better understanding the truths within these popular celebrations, we can better understand the modern world, and our place in it.
Many people in the modern world have rejected Christmas as being too commercial, claiming that this ritual of giving is actually a celebration of materialism and greed. Yet the true spirit of this winter festival lies not in the exchange of plastic toys, but in celebrating a gift from the earth: the fruiting top of a magical mushroom, and the revelatory experiences it can provide.
Instead of perpetuating outdated and confusing holiday myths, it might be more fulfilling to return to the original source of these seasonal celebrations. How about getting back to basics and enjoying some magical mushrooms with your loved ones this solstice? What better gift can a family share than a little piece of love and enlightenment?
FURTHER LINKS AND REFERENCES:

- The Hidden Meanings of Christmas, Mushrooms and Mankind, by James Arthur
- Who put the Fly Agaric into Christmas?, Seventh International Mycological Congress, December 1999, Fungus of the Month
- The Real Story of Santa, The Spore Print, Los Angeles Mycological Society, December 1998
- Santa and those Reindeer: The Hallucinogenic Connection, The Physics of Christmas, by Roger Highfield
- Fungi, Fairy Rings and Father Christmas, North West Fungus Group, 1998 Presidential Address, by Dr Sean Edwards
- Fly Agaric, Tom Volk’s Fungus of the Month for December 1999
- Father Christmas Flies on Toadstools, New Scientist, December 1986
- Psycho-mycological studies of amanita: From ancient sacrament to modern phobia, by Jonathan Ott, Journal of Psychedelic Drugs; 1976
- Santa is a Wildman, LA Times, Jeffrey Vallance
BOOKS WORTH READING:
- When Santa Was A Shaman: Ancient Origins of Santa Claus & the Christmas Tree, by Tony van Renterghem
- Mushrooms and Mankind, by James Arthur
- Soma: Divine Mushroom of Immortality, by Gordon Wasson
- Mushrooms, Poisons and Panaceas, by Denis R. Benjamin

Sunday, 11 November 2012

Psilocybin Therapy Documentary

adammushroom.png
In the spring of 2008, during an ayahuasca ceremony in the Peruvian Amazon, I met one of the NYU Psilocybin and Terminal Cancer therapists and my entire life changed. Within months he had helped me to find a job as a social worker in New York City and a new chapter in my life began. Four years later the research projects, which have taken place at UCLA, NYU, and Johns Hopkins University, continue to seek funding and new research subjects. A documentary film about the research was recently shot called "The Medicine: Science and Psychedelics." Considering my personal, albeit random, connection to the project, and considering that I too received tremendous healing from psychedelic plant medicines in the Amazon, I decided to request a sneak preview of the film. I found the documentary to be deeply moving and intellectually provoking.

 
"The Medicine" chronicles the therapy work of several terminal cancer patients who are given psilocybin as a form of both palliative and "end of life" care, to help cope with the fear of death.  The ability of the film maker to capture these delicate moments of deep healing and participant insight was truly amazing. After watching it several times over I decided to sit down with the producer and director of the new documentary, Roslyn Dauber, to ask her some questions about the film and to help promote these important psychedelic research projects.

Adam Elenbaas: Tell us about the film. What's it about and where did the inspiration come from?

Roslyn Dauber: This feature documentary is about current medical research with psilocybin.  We had the most open response and best access to these studies, at UCLA, Johns Hopkins University, and NYU.  It's just what opened up.  Documentaries aren't scripted, so they take on a life of their own.  I met Robert J. Barnhart, the executive producer through a friend.  He has a young child and was interested in having a kind of legacy documentary done about himself so she could understand him as an adult.  So I started poking around.  He has a lifelong commitment to this psychedelic research, is a lay leader, and has been crucial, in the early years especially, as a philanthropist.  He's a pretty unassuming person, so as I got to know him better, I said this is a really amazing story.  This research is so important in my opinion.  And we agreed to go ahead and start shooting.  In 2008 I had the incredible honor of having homemade cherry schnapps in Albert Hofmann's living room.  He was 102.  He died a few months later.  We may have the very last video footage of him.  He was such a radiant clear being.  And so, it went from there.... That day, and all the people we interviewed at the World Psychedelic Forum in 2008, including Stan Grof, Dennis McKenna, Franz Vollenweider, Kat Harrison and Rick Doblin, keeps me inspired.
 

Robert J. Barnhart with Albert Hoffman

Before making this documentary had you ever taken a psychedelic?

In the 80's I had a number of sessions with MDMA.  This profoundly affected my life.  I think that is why I instantly comprehended the value of psychedelic psychotherapy.

What did you learn from those experiences and how did it shape your path afterward?

You are going to like this one.  Have you ever heard of Dr. Muses? He was a mathematician into astrology and had this whole calendar based on Egyptian astrology... to do the substance ritually on a schedule.  The idea was that those times were especially auspicious to release difficulties and open our awareness. It's impossible to answer how it changed my life, because I don't have another life to compare it too.  I feel that I became more sensitive, open, and empathetic.  The sessions were spiritual experiences for me, letting me know that there is Spirit we can connect with.

After watching the film it seemed like all of the participants got something similarly profound but difficult to describe. How did the participants respond to you as a film maker and what were their experiences with psilocybin like?


The volunteers were extraordinary.  Two of our subjects -- Annie Levy and Matt Meza -- died shortly after we got to know them, of cancer.  They both felt the sessions were of invaluable service them, allowing them to resolve some issues and make peace with their coming deaths. The healthy normal study volunteers at Johns Hopkins University had just as powerful experiences, with gentler futures to look forward to.  Sandy, another participant, said it was the most significant spiritual experience she's ever had, and her life is still unfolding in ways the session guided her to. There is a state of consciousness where words are not adequate, awesome.  That is what these volunteers reported.

It's such important work and so good for people to see how these medicines can be used in constructive, clinical settings. Did you have a particular audience in mind when you made the film?

It is important work. Yes. Right now my greatest fear is not raising the money to finish the flim.  We are doing our crowd-funding campaign and although many people donated, we didn't meet our goal. The intended audience is a wide PBS audience, people not familiar with the medicines, or even people who believed the rhetoric of the War on Drugs.

I will ask you again later how we can donate toward the completion of this film and where the research project is at overall, but next I want to ask you a question about shamanism. After watching the film for as struck as I was by the results I also wondered about the indigenous shamanic context. Some people might criticize that indigenous shamanic practitioners or shamanic training are necessary parts of the therapeutic value of this plant medicine. Have either of you had experience with shamans or shamanic training? How about the researchers/doctors and therapists?

This is a big question.  I respect shamanic traditions.  I have been very fortunate as a documentary filmmaker to be allowed to witness amazing things.  I spent time on second Mesa in Hopi while shooting Broken Rainbow.  I've been to the ancestral land of the pre-Buddhist Tibetans, the Bonpo, filming ceremonies in monasteries in Tibet built in 1000 AD.  I've been to Huichol country during their peyote hunts.  I have been in ceremonies in the Andes.  That said, I'm still a very white pale face.  Anthropologist Jeremy Narby talks about this most eloquently and his ideas have been very helpful for me.  The point is this feature doc is about psilocybin research in the medical schools.  It follows a protocol and addresses the rigors of the Western scientific method.  The goal is to make these medicines legal by prescription in this country.   The guides are psychologists and psychiatrists.  That said, having the pleasure to get to know them, they are all very aware of the pscyhe, the inner workings of the human mind, spiritual experience, ego death. and inner exploration.  I think of them as contemporary 21st century shamans in the Western medicine tradition.  How do things get translated cross-culturally? I think this is a good question and I think these researchers do a great job with good integrity.

I agree. I've met several of the researchers and know that many of them have deep love for and personal experience with shamanic medicine ceremonies and tradition. Next question for you. Where do the psilocybin projects stand today and where can people find more information about them or donate or participate?


Annie's study was at UCLA (she's the one in the preview and featured in our film). That study is complete. Current studies are at Johns Hopkins University and NYU.
 And yes, they are looking for volunteers.  The Heffter Research Institute has all the information about the research.

Wonderful. We've attached the film preview at the bottom of this article for people to check it out. So where can folks find more information and where are you guys at with the film itself? You're still fundraising?

The film isn't finished yet and that's why we need help fundraising! People can sign up on our website for updates if they give their email address, 
and donate by  going to the fundraising page on  the website www.themedicinescienceandpsychedelics.com
. The money will go toward editing -- to the editor and sound editing and music editing -- color correction and audio mix.  We'd like to do one more shoot -- with Ram Dass as he has said that his early LSD work led him onto his spiritual path.  We're looking for a celebrity narrator.  And some money will be saved for marketing and distribution -- we'd like to show it in art houses in all the cities the research is being done in.  Any size donation is welcome, as are people's emails, because in addition to needing the funds, it shows there is interest in the film and makes it easier to find distribution.  We already have a great educational distributor, but want to have a theatrical run.

Well here at Reality Sandwich we are big supporters of this kind of research so our readers will be happy to check it out and donate I'm sure! Roslyn, what else are you up to these days? What other films have you worked on in the past and what are you looking forward to?

Right now I'm focused on finishing this film of course. I think it's very important and has huge potential to educate the public and create awareness that could lead to substantial change around the legality of these medicines. The last docs I've done are: One Gay One Straight, about what happens in a marriage when one spouse comes out; Teen-Age Moms -- Wyoming, about unwed teenage moms in a program to give them lifeskills in Cheyenne, Wyoming; and Upward & Outward -- Scientific Inquiry on the Tibetan Plateau, which explores why the the Himalayas are the fastest rising place on earth geologically.  I produced and directed Tara's Daughters about Tibetan women refugees.  We got to interview HH the Dalai Lama about his mother and whether he'll ever come back as a woman. He said its a possibility...

In development is a series about neuroscience and magic -- what neuroscientists can learn about imaging from masters of the sleight of hand.   I'd very dearly love to turn the Medicine: Science and Psychedelics into a short series with an episode each on MDMA, LSD, IBOGAINE, AYAHUASCA, PSILOCYBIN, and PEYOTE.  I'm really interested in how people get information and how that effects policies made.  I worked on Capitol Hill as a science policy analyst and I was a journalism professor. My first professional job in film was as Associate Producer of Broken Rainbow about the Hopi / Navajo land dispute.  It won the Academy Award that year for Best Feature Documentary.  Because I have done film work with indigenous people I've been allowed to witness rituals and well, miracles.   Everything I do is about how science and technology effects people's lives, including medicines.  I'm a dzogchen practitioner and on some level believe everything about our human experience is determined by our state of mind.

Truly a privilege to have you sharing with us here at RealitySandwich. We wish you the best of success on your journey and with this important film, "The Medicine: Science and Psychedelics." Thank you so much for taking the time to speak with us.

Sunday, 12 August 2012

Richard Dawkins on Psychedelics

4013054714_03934428eb.jpg

In this video, alternative historian and Reality Sandwich contributor Graham Hancock asks Richard Dawkins, famous anti-mystic and author of The God Delusion, about the possibility of psychedelics changing his view of reality. Dawkins responds thoughtfully about the prospect of trying LSD or mescaline, and speaks positively of those who have had the experience. Given Dawkins's reputation as a staunch atheist, his open-minded answer may surprise many of his critics.

Sunday, 29 July 2012

Safe Rolling

epill.jpg


Can pure ecstasy, known as MDMA, be taken safely by adults? Dr. Perry Kendall, a British Columbia doctor, says yes, it can.

Kendall says that he is not advocating for the drug to be legalized. According to him, he is asking a "hypothetical question," which is: "If those drugs were to be legalized, what would be the best way of doing it?"

Still, Kendall critiques the way the Canadian government is going about regulating and controlling psychoactive substances. He says that Canada should approach it in an "evidence-based way," by looking at "what works and what doesn't work." The current "regulatory regime" is, according to Kendall, "not optimal."

Essenctially, Kendall is arguing for drug policy to be based wholly on empirical evidence. That does seem most logical, and it is not unlike the arguments made by marijuana legalization advocates here in the United States.

Kendall compares MDMA to alcohol, which, like ecstasy, can be dangerous, even fatal, if abused. Alcohol can be arguably more dangerous that MDMA.

He also says that MDMA, if taken under the right circumstances in non-toxic dosages, can treat mental conditions such as post traumatic stress disorder.

Medical literature ascribes the euphoria and social intimacy of MDMA to the waves of serotonin it sends flooding through the brain.

His rhetoric continues to run parallel with marijuana advocates here in the US: "What is fundamentally the difference between that and a psychoactive substance that makes people feel good and gives them some energy, which as far as we know isn't addictive, doesn't cause cancer, doesn't destroy the brain?" he asks.

But other findings run counter to this. The Royal Canadian Mounted Police in B.C., who have a team dedicated to finding illegal drug labs, maintain that no amount of the substance is safe. Toronto's Centre for Addiction and Mental Health has a list of MDMA's potential health effects, which include teeth grinding, sweating, increased blood pressure and heart rate, anxiety, blurred vision, nausea, vomiting and convulsions, even at low doses.

Steve Outhouse, a spokesman for Health Minister Leona Aglukkaq, responded to Kendall's statements, saying, "Our government is not contemplating any changes that would make ecstasy legal, so we have no further comment to make at this time."

Still, the medical establishment widely agrees that the substance is not addictive, and new research suggests that the negative effects associated with the drugs may be exaggerated.

Despite all this debate, MDMA still remains a highly criminal substance in Canada. It was recently put at the top of Canada's drug scheduling list under the federal governments omnibus crime bill, carrying similar penalties to cocaine and heroin.

The fact this discussion about MDMA is even happening is a positive step. The drug may continue to frighten some people for the foreseeable future, which is an understandable effect of Reefer Madness-esque scare tactics, not to mention all too real tragedies that have resulted from its abuse. Hard facts and solid drug education based on the empirical approach that Kendall is in favor of may ultimately be the most effective way to protect public safety.

Image by Chris Breikss, courtesy of Creative Commons licensing

Sunday, 8 July 2012

Criminalising Drugs is Harming Medical Research – An Interview with Professor David Nutt

David Nutt, former adviser to the UK government, says the ban on drugs like ecstasy is hampering neuroscience

"I can show you 150 papers telling you how the brain reacts  to an angry face, but I can't show you a single paper that tells you  what cannabis does." <i>(Image: Tony Buckingham)</i>

"I can show you 150 papers telling you how the brain reacts to an angry face, but I can't show you a single paper that tells you what cannabis does." (Image: Tony Buckingham)

How do the drug laws in most countries affect scientific research?
One of the things I find very disturbing about the current approach to drugs, which is simply prohibition without necessarily any full understanding of harms, is that we lose sight of the fact that these drugs may well give us insights into areas of science that need to be explored and may give us new opportunities for treatment.

In what way?
Almost all the drugs of interest in terms of understanding brain phenomena such as consciousness, perception, mood and psychosis are illegal. And so there is almost no work done in this field.

How bad is the impact?
The effects these laws have had on research is greater than those caused by the US government hindering stem cell research. No one has done an imaging neuroscience study of smoking cannabis. I can show you 150 papers telling you how the brain reacts to an angry face, but I can't show you a single paper that tells you what cannabis does.

Any examples of missed opportunities?
There were six trials of LSD as a treatment for alcoholism, the last one in 1965. The evidence is it's as good as anything we've got, maybe better. But no one is using it for this. I wonder how many other opportunities have been lost in the past 40 years with important drugs, like MDMA (ecstasy) and its empathetic qualities or cannabis for all its possible uses and insights into conditions like schizophrenia. All those opportunities have been wasted because it is virtually impossible to work with a drug when it is illegal.

How do you see change coming about?
The scientific bodies in the UK are the ones that should really be challenging the government. I will try to get the Royal Society and the Academy of Medical Sciences to support my campaign for a more rational approach to the regulation of drugs for research.

You were sacked as a UK government adviser for comparing the risks of horse riding with taking MDMA. Do you still take this line?
It is still a very important discussion. It raises the question of what the appropriate comparisons are. Where do you draw the line on harm? Should it be drawn equally across all sorts of endeavours and activities that humans engage in?

Should recreational-drug laws be relaxed?
If you are using a drug less dangerous than alcohol, that is a rational choice. If you are using drugs that are more harmful than alcohol, essentially heroin or other forms of opiates and crystal meth and cocaine, then that's different.

As head of the UK Independent Scientific Committee on Drugs you've written a book, Drugs: Without the hot air. Who is it for?
Parents and those with no scientific background can read it, children can read it and hopefully the media and politicians will read it. I hope we can start having more of a discussion about drugs.

Profile

David Nutt is the Edmond J. Safra Professor of Neuropsychopharmacology at Imperial College London. He headed the UK Advisory Council on the Misuse of Drugs technical committee for seven years

Sunday, 1 July 2012

LSD as a Spiritual Aid

mandala.jpg

The following is excerpted from Spiritual Growth with Entheogens edited by Thomas B. Roberts, available from Inner Traditions.

Albert Hofmann, Ph.D., Dr.Pharm.H.C., Dr.Sc.Nat.H.C., is best known for his serendipitous discovery of LSD and for his chemical work identifying the active principles of the sacred mushroom of Mexico. He was the retired director of research for the Department of Natural Products at Sandoz Pharmaceutical Ltd. in Basel, Switzerland. Dr. Hofmann was a fellow of the World Academy of Science and a member of the Nobel Prize Committee, the International Society of Plant Research, and the American Society of Pharmacognosy. He wrote many scientific papers and several books: The Botany and Chemistry of Hallucinogens and Plants of the Gods with Richard Evans Schultes, The Road to Eleusis with R. G. Wasson and Carl Ruck, LSD: My Problem Child, and Insight/Outlook.

Born January 11, 1906, Albert celebrated his 100th birthday in excellent health with thousands of grateful admirers at the Spirit of Basel -- a celebration of his life's work (www.lsd.info/en/home.html). Albert died two years later, on April 29, 2008, four months after his wife, Anita, had passed away. His archives and legacy are managed by Dieter Hagenbach at www.gaiamedia.org.


The use of soma (which is the Iranian haoma) is one among many examples of the religious use of drugs and intoxicants that have strange psychological effects. In our own day, Aldous Huxley has advocated the use of mescaline. The weird and glorifying properties of such plants and concoctions have given man a heightened religious experience, a window, as it were, on a world that is normally beyond the range of humdrum senses. --Ninian Smart, The Religious Experience of Mankind, 1984

Before I start with the report on the role LSD has played in my spiritual development, some general remarks on this very special psychopharmacon are appropriate.

LSD is not a product of planned research. I did not look for it, it came to me. This means to me that a higher authority thought it was necessary now to provide mankind with an additional pharmacological aid for spiritual growth.

LSD is not just a synthetic substance from the laboratory. After the discovery of lysergic acid amide and lysergic acid hydroxyethylamide (very closely related to lysergic acid diethylamide) as the entheogenic principles of Ololiuqui, an ancient sacred plant of Mexican Indians, LSD had to be regarded as belonging to the group of natural entheogenic drugs of Mesoamerica.

These two characteristics of LSD legitimate its use in a religious framework.

Now I come to the report of how LSD was a spiritual aid to me and how it influenced my worldview (Weltanschauung).

After my first experiences with LSD, the question arose for me: Which is true, the picture of the world as we perceive it with our everyday consciousness or the overwhelming image under the influence of entheogens?

This caused me to analyze what we know about the mechanism of perceiving reality.

Perception presupposes a subject that perceives and an object that is perceived. In human relations the subject that perceives is the individual human being, more exactly his consciousness, and the object perceived is the outer material world.

It is of the greatest importance to be aware of the fundamental fact that the outer world consists objectively of nothing more than matter and energy.

In order to make conspicuous the mechanism of our experiencing reality, I have chosen a metaphor from television. The material world functions as transmitter, emanates optical, acoustical, gustatory, olfactory, and tactile signals that are received by the antennae, by our sensory organs, eyes, ears, tongue, nose, and skin and are conducted from there to the corresponding center in the brain to the receiver. There these energetic and material signals are transformed into the spiritual phenomena of seeing, hearing, tasting, smelling, and touching. One does not know how this transformation of material and energetic impulses into the psychic dimension of perception takes place. It includes the mystery of the connection between the material and the spiritual world.

The transmitter-receiver metaphor of reality makes evident that the picture of the outer world comes into existence inside, in the consciousness of the individual.

This fundamental fact signifies that the screen on which the colorful world is perceived is not in the outer but in the inner space of every human being. There are no colors, no sounds, no taste, no odors in the outer world. Everyone carries within himself his own personal image of the world, an image created by his private receiver. There is no common screen outside. This makes us fully aware of the cosmogenic (worldcreating) power invested in every human.

Before making use of these considerations to explain the ability of LSD and the other entheogens to change the experience of reality, our knowledge about the essence of consciousness must be reviewed.

Consciousness defies a scientific definition and explanation; for it is what is needed to contemplate what consciousness is. It can only be circumscribed as being the receptive and creative center of the spiritual ego, which has the faculties of perceiving, thinking, and feeling, and which is the seat of memory.

It is of fundamental importance to be aware of how consciousness originates and develops.

The newborn human possesses solely the faculty of perceiving -- possesses, or more correctly, is this mystic nucleus of life. He owns -- to use again the metaphor of television -- a blank videocassette, where the incoming stimuli from the outer world are transformed into images and sensations that can then be stored in the memory, providing the groundwork for thinking. Without these signals from outside, no consciousness could develop.

There is common consent that the evolution of mankind is paralleled by the increase and expansion of consciousness. From the described process of how consciousness originates and develops, it becomes evident that its growth depends on its faculty of perception.

Therefore every means of improving this faculty should be used.

The characteristics of entheogens, their faculty to improve sensory perception, makes them inestimable aids in the process of expanding consciousness.

It was LSD, the most potent entheogen, that, to use Blake's famous line, cleansed my doors of perception and made me see everything as it is, infinite.

In my childhood I experienced spontaneously some of those blissful moments when the world appeared suddenly in a new brilliant light, and I had the feeling of being included in its wonder and indescribable beauty. These moments remained in my memory as extraordinary experiences of untold happiness, but only after the discovery of LSD did I grasp their meaning and existential importance.

As mentioned at the beginning of this short essay, it was my experiences with LSD that caused me to think about the essence of reality. The insights I received, as described, increased my astonishment about the wonder of existence, of which we become conscious in enlightened moments.

Teaser image by Peter Kaminsky, courtesy of Creative Commons license.

Sunday, 10 June 2012

DMT, Creativity and a Philosophy of Psychedelics

DMTRMX_LOGObig.jpg

Join the director of DMT: The Spirit Molecule on a co-creative journey into transformational film-making and learn how you can help mix the open-source code for a new planetary culture. This Evolver Intensives live, online video course, "DMT RMX: Transmedia to Transbeing," starts on June 24th.

A version of this interview appeared in Catalyst.

Following his first experience with DMT, Director Mitch Schultz was inspired to create a series of four documentary films beginning with DMT: The Spirit Molecule. The films go first to understanding our connection with heaven, dimensions beyond our 3D world, and realms wholly different from our everyday reality. Second is Ground of Being, focused on understanding how to harmonize our relationship with our natural environment. Next is Global Beat Fusion, examining music as the soul of culture. The whole project concludes with a film focused on communication -- how to relate about all these experiences with each other.

Terra: Mitch, thank you so much for taking time for this conversation. You Directed The Spirit Molecule, which follows Dr. Straussman's sanctioned study of a psychoactive substance found naturally in plants, animals and humans, dimethyltryptamine. Why did you decide to make a film about DMT? Had you heard of Dr. Strassman's work previously?

Mitch: The simple answer, a personal DMT experience in 2002. Prior to that experience, I had never heard about Dr. Strassman's research, but it was that experience that brought me to his work. A close friend was moving home to Brazil from NYC, and several of us gathered in a midtown apartment to see him off. One of the individuals brought a small amount of DMT, and as it turned out, he was the only one there that had ever heard of DMT. I considered myself an experienced psychonaut and explained to him that I knew what to expect from my past psychedelic explorations. He quickly laughed me off. I was the third one to take the DMT, and by the second inhalation things began to shift very quickly. He encouraged me to take two more inhalations (I'm still not sure how I pulled that off), and immediately went into what I can only explain as dying experience. I had never been so afraid, and did my best to hold on. After approximately one minute the fear passed, and it turned out to be one of the most beautiful experiences in my life. Almost immediately upon my return to consensus reality, I knew I would make this film. The 10-minute experience changed the core of my being, provided a drastically new outlook on life, and ultimately became the impetus for my psychedelic research and life direction.


What is the focus of your current psychedelic research?


Healing, personal growth and spirituality. Now of course all of these can intersect with the next, but without two of the three present it's not worth going there. Ultimately, I believe the core of what we search for as humans lays at the intersection of all three, so I put my focus on uncovering ways to make them overlap. I've always had a sense that psychedelic mindspace is fully integrated with a multi-dimensional matrix of "life" that can be mapped, navigated and shaped in unimaginable ways. Reality hacking.


In your experience, do psychedelics only act on the mind?

Right, is like, your brain on drugs or close encounters of the third kind? I've come to think it's a combination of both. The cathartic emotions, shifts in time and space, entity communication, physical healing, and the variety of other experiences that we just can't wrap a vocabulary around seem to be more than just an internal occurrence. Science (as spiritual philosophies) continues to discover ways that our entire being is networked on multiple levels of reality, which becomes very apparent with altered states of consciousness connected to an interactive biological matrix. My sense is that the brain opens up its range of sensory awareness bringing insight into our mind, but at the same time we experience a variety of other energetic forces that remain hidden in consensus reality and play a role in our everyday life.

Psychedelic immediacy gives an experience of life unbounded. Through the freeing of thoughts and mind, psychedelic experiences can reveal the mystery of human potential, which is infinite. Can you describe life in a psychedelic world? Is this a good idea?


Phantasmagoric.

The dream, the reality, the imagined, all are contributing to the conditions of daily life -- each of these arenas has influence in our thoughts, habits and decision making. Examined close up, even the most still parts of life are full of movement and dynamic change. Rocks erode. Everything is in a constant state of decay or rejuvenation. In considering a state of psychedelic cohesion, is a psychedelic state a more immediate and direct awareness of this actual and constant reality?

Through personal trials and tribulations, I've come to understand my journey as a way to offer help to humanity with the concepts that have been revealed to me. And although the last decade has allowed me to solidify my musings, it has been a lifelong process. The culmination of my 38 years on this planet has resulted in a tetralogy of projects that make up the four-part Manifesto, a manifesto that aims to redefine our connection to Spirit, however understood or represented by any individual or larger culture.

Many have seen your documentary The Spirit Molecule, the first part of this Manifesto. Please share with us how you see the whole manifesto taking shape.

It begins with DMT: The Spirit Molecule exploring a new paradigm for consciousness, quantum consciousness. At the center of awareness lies a simple, natural molecule that potentially exists in all living organisms. A molecule that consistently produces a mystical experience, and may be the seed to the ultimate connection to It. Viewed through the lens of Entheogens, consciousness encounters the quantum world, generating and fostering Gnosis, but this state of consciousness can also be explored via a variety of ancient and esoteric knowledge around the world.

The next film, now in editing, Ground of Being documents a thriving eco-village built as an effort of restoration, rehabilitating an exhausted bluestone quarry in Melbourne, Australia. The community of C.E.R.E.S. has created and now maintains an award winning, not-for-profit, environment and education centre and urban farm.

Ground of Being builds from the knowledge attained from quantum awareness, and addresses humanity's role and symbiotic relationship to the life force of Earth. Through food and general sustainability practices, our physicality, thought, emotions and behaviors directly relate to how we recognize and care for natural world. By acknowledging our connection to everything around us, we can create a successful realignment with Nature that begins with the individual, grows into local community, and blossoms into a well integrated whole, mimicking the life force that we exist in.

The third film, Global Beat Fusion (based on Derek Beres' book of the same title), examines the interpretation, and celebration, of Spirit through music (art). Music has always been a ritual and social activity, a personal connection and a communal art shared by many. Music is the soul of a culture. Global Beat Fusion uncovers the computer as the first global folk instrument that international musicians share their respective cultural soul via the electronic space, cross-germinating their mythologies to create a meta-mythology.

Your work on this Manifesto begins with a vision resulting from your first DMT experience. You became aware of a possible peaceful world -- a sustainable reality. This was brought to light by your experience of a well balanced realm -- so you were inspired to share this Vision through the creation of this Manifesto comprised of four documentary films, ultimately concluding with a re-view -- re-telling the story.

This work concludes with the communication component. Open Source Reality [a working title] asks for the evolution of consciousness, physicality and interpretation of Spirit. For this to take place we need to develop a new language of maps, models and metaphors to re-interpret the misguided mythologies that have directed humanity for millennia, and now plague the social fabric.

The DMTRMX project creates an opportunity for anyone interested to become engaged in the psychedelics conversation through experiencing a dynamic and audience participatory approach to film and editing. You've given access to The Spirit Molecule anthology to the global community via the Creative Commons license, allowing creative individuals global access to edit and create their own DMT on film experience. What are your thoughts on intellectual property vs idea sharing?

Rather than 'property' think abundance, an intellectual smorgasbord. Open source ideas, believing the source of inspiration is infinite. Through this open sourcing and idea sharing, we redefine our mythologies, incorporating the quantum physical realm. We are constantly connected and related to a heavenly presence and source. Additionally, data is prolific throughout the world and by the internet, all this information is now broadly accessible, allowing the (re)discovery of lost traditions and and illuminating a clearer understanding of new and emerging tribal beats, new stories, new technologies and innovations, new mythologies created and shared.

Sunday, 25 March 2012

The LSD Cure

5678495403_74fc86740d.jpg

According to a recent study by Krebs (a neuroscientist) and Johansen (a clinical psychologist), LSD may help treat alcoholism. This study was the first-ever quantitative and clinical meta-analysis of the efficacy of LSD in treating alcoholism. Krebs and Johansen performed thousands of random, double-blind trials comparing LSD to a placebo. Of those who were given LSD, 59% attested to lower levels of alcohol consumption compared to 38% of those who were given a placebo. Krebs explains that these results have been consistent, and that the positive lifestyle-changing effects of LSD lasted up to six months for some patients.



How a single dose of LSD can have such a profound effect remains somewhat of a mystery. LSD has a similar structure to serotonin, a neurotransmitter responsible for feelings of pleasure. However, LSD triggers quite different responses to the serotonin-receptor site and also acts at several other receptor sites.



Perhaps we have to zoom out from the microscopic level of neurotransmitters and synapses to understand how hallucinogens can have such a powerful effect on human behavior. Carhart-Harris, a psychopharmacologist at Imperial College London states that psychedelics work at both biological and psychological levels—as if the two, mind and body, can even be conceived of as separate! He suggests that psychedelics help addiction by making the brain function more chaotically for a period, “like shaking up a snow globe, weakening reinforced brain connections and dynamics.” Whether taken with a therapeutic intention or not, psychedelics surely have this power to shake things up, to project before one’s own eyes (and third-eye) in typically dramatic visions, those un-integrated shadow aspects of one’s own psyche which need attention. Their ability to show us how certain habits of thought and deed are affecting us on multiple levels, reveal that psychedelic therapy may really help addiction.


Image by yampyank on Flickr courtesy of Creative Commons Licensing

Sunday, 5 February 2012

Magic Antidepressants

trippy.jpg

Continued studies on the effect magic mushrooms have on the brain are showing that psilocybin, the active ingredient of psychedelic mushrooms, affects key parts of the brain in ways that relate to depression and anxiety disorders.

Robin Carhart-Harris, a post-doc in neuroscience at Imperial College London, and lead author of the studies on psilocybin's therapeutic effects, says that psychedelics can lift people away from negative modes of thinking, especially for those who suffer from depression. So far, the results from experiments with volunteers have supported this theory. Ten subjects reported that recalling happy memories was a much more "vivid, visual, and happy" experience with psilocybin as opposed to without.

"The brain's doing a lot to keep our experiences of the world orderly and constrained," says Carhart-Harris. The parts of the brain that try to structure our perception of the world, keeping it rational and safe, are suppressed by psilocybin, resulting in vivid emotional experiences. These areas of the brain function differently in people that have mental health issues such as depression, hence the speculation that the drug may be useful in treating mental illness.

In another study, 30 volunteers underwent brain scans in an MRI machine while under the influence of psilocybin. The brain scans showed less activity in the posterior cingulate cortex, which is thought to have a connection to consciousness and ego, and is hyperactive in people with depression.

Less brain activity was not what the researchers expected to find. The fantastical nature of psychedelic trips has always been attributed to overactive brain activity. It's not surprising that misinformation still surrounds the field - serious psychedelic research was shut down during the 60s, a time when psychedelic culture was a national scare.

Fortunately, recent studies such as this allow for psychedelics to be given serious consideration. Other small studies found improvements in people who suffer from obsessive compulsive disorder, as well as improved mood and lessened anxiety in cancer patients.

The experiences are not uniformly positive - 39% reported anxiety and fear. There are trained monitors that stay with the subjects to lessen any negative reactions.

Still, research continues, and Carhart-Harris plans to answer the question of whether psilocybin does significantly help the symptoms of depression.

Visible Language by Felipe Venancio on Flickr courtesy of Creative Commons Licensing

Sunday, 15 January 2012

Integral Pychedelics: Tripping and the Word of God


Uploaded by on 9 Jan 2012

Integral Pychedelics: Tripping and the Word of God by http://www.NeuroSoup.com

During many of my trips, I experienced a language that came to me in the form of chants and songs. It wasn't a language I'd spoken before yet it seemed as though it was the language that formed reality. Likewise, it felt familiar. Oh so familiar. It was precious and full of love. It was like the one mind had enveloped me and was flowing through me, as it always is. The eternal now given voice. It helps me navigate altered states, fills me with light, and gives me strength.

And ever since those initial trips, I've sought out people who have shared similar experiences as mine. One of these people I believe is John, the apostle of Jesus in Christianity.

Sunday, 8 January 2012

Edible Mushrooms: Nature's Most Researched Anti-Cancer Agent

Sayer Ji, Contributing Writer
Activist Post

Over the course of the past few years we have uncovered a remarkable body of research on the medicinal properties of mushrooms.

In fact, when it comes to natural cancer research, no other category has been the subject of more human clinical research than AHCC and Lentinan, both unique preparations of shiitake mushroom.

AHCC stands for active hexose correlated compound, and is classified as a functional food made from hybridized mycelia of shiitake (and sometimes other mushrooms) in rice bran. It contains both alpha- and beta-glucan polysaccharides, well-known modulators of host immunity. Lentinan, also from shiitake (Lentinula edodes), is exclusively beta-glucan. What is so unique about these compounds is that they are "host-mediated" anti-cancer agents, helping the cancer-afflicted body combat cancer by boosting immune function.

This is a radically different approach versus conventional chemotherapy, which poisons rapidly dividing cells, indiscriminately, killing both cancer and immune cells (among other healthy cell types).

How can edible mushrooms like shiitake protect us against cancer, perhaps the most widely feared disease that presently afflicts our species? Could the reason be that we co-evolved with fungi, and that the essential polysaccharides they contain were present in our diet for so long that the genetic/epigenetic infrastructure of our bodies now depends on them? Beta-glucan, after all, is found widely distributed in whole grains, nutritional yeast, as well as fungi. The friendly bacteria, in and outside of our gut, produce the beta-glucan fraction through the biotransformative processes of digestive fermentation and, in the case of food, culturing. Could it be that, failing to consume (or produce) adequate quantities, our body fails in its cancer immunosurveillance -- not unlike the well-established role that vitamin D deficiency has in maintaining proper immune function, and therefore reducing cancer risk.


But perhaps there is an even deeper reason to why fungi keep us alive and well, even when faced with the most terrible of health challenges: we share a common, unique evolutionary origin, and our fates may still be intimately interwoven.

The microbiologist Mitchell Sogin was interviewed back in 2004 on the topic:
'Animals and sponges share a common evolutionary history from fungi...
...we thought fungi were related to plants or somehow were just colorless plants. Plants had seeds, fungi had spores, and so on. Scientists used to publish fungi articles in plant journals. But the work does not support that. We've shown that fungi and plants are very different from each other, and fungi are actually more closely related to animals.'
When asked the question: "Does all this mean humans are just highly evolved mushrooms?" Sogrin answered:
I'd say we share a common, unique evolutionary history with fungi. There was a single ancestral group of organisms, and some split off to become fungi and some split off to become animals.'
Could medicinal/edible mushrooms "lend us their power"? In certain traditions of herbalism, there is an acknowledgment of the sacred bond between patient and herb, where the plant lends its power to (s)he who is suffering, as a "plant ally." Beyond nutritional and caloric content, biochemical make-up, pharmacology, etc., certain fungi may embody the biological equivalent of compassion, and exude an abundance or superfluity of life energy that we may harness to correct imbalances within ourselves.

First, we must be willing to acknowledge that power in a source outside of ourselves, which is difficult for egocentric, anthropocentric humans to do. Second, we must consider ourselves worthy of the miracle of being healed, of life regenerating itself through us.

To learn more about the sacred bond between fungi and humanity, as well as how "mushrooms may save the world," please watch Paul Stamet's amazing video on the topic below...



Please visit GreenMedInfo to access their vast database of articles and the latest information in natural health.

Sunday, 27 November 2011

Psychedelic Sunday roundup

week_psychedelics.jpg

Deepak Chopra's psychedelic experiences inspire a new meditation video game for Kinect and Wii, Bill Maher describes acid as safer than processed sugar and "mind-narrowing pharmeceuticals", and brain scans reveal the "reality" of ayahuasca visions in this week's psychedelic news.

  • Leela, a new meditation and chakra-based game for Kinect and Wii, was inspired by spirituality guru Deepak Chopra's early experiments with psychedelic drugs. (Wired)
  • Bill Maher explains the value of tripping on acid, and why "it's one of the least harmful drugs a child could ever take." (Mediaite)
  • A study correlates high IQ in children with subsequent use of illegal drugs, including "cocaine, cannabis, LSD (acid), heroin, downers (tanks, blues, barbiturates), and uppers (speed and wiz)". (Medical News Today, TIME)
  • A study suggests that LSD use in Australia has increased significantly in the last year. (Sydney Morning Herald)
  • Brazilian scientists report ayahuasca visions may be as real as anything the eyes actually see, according to brain scans of activity in the primary visual cortex. (New Scientist)
  • Amazonia, a new documentary by Alberto Villoldo, addresses the power of healing with jungle plants. (Technorati)
  • A new film looks at the work of a Canadian doctor and author who travelled to the Amazon to larn about ayahuasca, a psychotropic medicine that may help drug addicts recover. (Yahoo News)
  • This same Canadian doctor, who allowed a film crew to document his use of ayahuasca to help treat drug addiction, has been ordered to end his treatments. (CBC News)
  • Canadian researchers have sequenced the genome of Cannabis sativa, the plant that produces both industrial hemp and marijuana, revealing the genetic changes that led to the plant's drug-producing properties. (Science Daily)
  • David Jay Brown explains how ibogaine, a derivative of the psychoactive African plant iboga, can offer hope for people with severe drug addictions. (Santa Cruz Patch)
  • An article reviews recent evidence that MDMA and other illegal drugs like LSD and psilocybin mushrooms can help treat post-traumatic stress disorder (PTSD). (Miller-McCune)
  • A feature article describes NYU's project using psilocybin-assisted psychotherapy to treat end-of-life distress in people with cancer, and the current state of palliative care in the United States. (Institute of Noetic Sciences)
  • James Fadiman, PhD describes the growing field of psychedelic psychotherapy research. (Institute of Noetic Sciences)
  • The Multidisciplinary Association for Psychedelic Studies will be celebrating 25 years of research and education from December 8-12 in Oakland, CA. (Santa Cruz Patch)
  • The Ecuador National Assembly is to begin a debate on the decriminalization of possession of drugs for personal use. (Talking Drugs)
  • Juan Manuel Santos, the Colombian president, has called for the global legalization of marijuana to help combat the trafficking of harder drugs and related violence. (Telegraph, Guardian)
  • A Forbes article highlights the many failures of the drug war, asserting that "it's time to declare peace in the war against drugs." (Forbes)


...MORE HERE...